Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Return on Assets (2021 - 2025)

Historic Return on Assets for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to 0.1%.

  • Janux Therapeutics' Return on Assets fell 100.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.1% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Janux Therapeutics' Return on Assets is 0.1%, which was down 100.0% from 0.1% recorded in Q2 2025.
  • Over the past 5 years, Janux Therapeutics' Return on Assets peaked at 0.05% during Q3 2021, and registered a low of 0.2% during Q2 2023.
  • Its 5-year average for Return on Assets is 0.12%, with a median of 0.1% in 2024.
  • As far as peak fluctuations go, Janux Therapeutics' Return on Assets tumbled by -1100bps in 2022, and later skyrocketed by 1300bps in 2024.
  • Quarter analysis of 5 years shows Janux Therapeutics' Return on Assets stood at 0.08% in 2021, then tumbled by -101bps to 0.17% in 2022, then rose by 11bps to 0.15% in 2023, then soared by 48bps to 0.08% in 2024, then decreased by -26bps to 0.1% in 2025.
  • Its Return on Assets stands at 0.1% for Q3 2025, versus 0.1% for Q2 2025 and 0.07% for Q1 2025.